Heart Conditions & Polygraph Testing: Safety & Accuracy

The Cardiovascular Channel Explained

A modern polygraph instrument records physiological data across multiple channels simultaneously. While the electrodermal activity (EDA) channel and pneumograph channels capture skin conductance and respiration respectively, the cardiovascular channel — formally known as the cardiosphygmograph — measures blood pressure changes, heart rate, and pulse amplitude via a blood pressure cuff placed on the upper arm [4]Verified PDD Terminology Reference for the Science of Psychophysiological Detection of Deception
Confirms polygraph cardiovascular channel terminology, blood pressure cuff placement, and that the dicrotic notch has not been found to be a reliable diagnostic feature in PDD.

The cardio cuff is typically inflated to approximately 60 mmHg, which is enough pressure to detect arterial volume changes without causing discomfort during the 3-5 minute chart collection periods. The transducer inside the cuff converts mechanical pulse waves into electrical signals that are digitized and displayed as a continuous waveform on the polygraph software. For a deeper understanding of how examiners evaluate these signals, see our guide to the role of the polygraph examiner.

What the Cardio Channel Captures

The cardiovascular waveform provides examiners with several critical data points used in numerical scoring and algorithmic analysis:

Relative blood pressure changes — the overall rise or fall of the baseline during relevant vs. comparison question sequences. Early pioneers including Marston (1917) and Larson (1922) documented that elevated blood pressure responses occurred when individuals engaged in deception [5]Verified The Polygraph and Lie Detection
Confirms that Marston (1917) and Larson (1922) found elevated blood pressure responses during deception, and provides foundational review of polygraph science including cardiovascular measurements.

Heart rate variability — changes in the interval between heartbeats (R-R interval), which reflect autonomic nervous system activation.

Pulse amplitude — the height of individual pulse waves, which decreases during sympathetic activation (vasoconstriction) and increases during parasympathetic dominance.

Dicrotic notch characteristics — the secondary wave visible in each pulse cycle that provides information about peripheral vascular resistance, though it has not been found to be a reliable diagnostic feature in polygraph testing [6]Verified PDD Terminology Reference — Dicrotic Notch
Confirms the dicrotic notch has not been found to be a reliable diagnostic feature in PDD.

Research consistently demonstrates that cardiovascular measures contribute significantly to overall polygraph accuracy. A comprehensive meta-analytic survey of validated polygraph techniques found that event-specific diagnostic tests achieved 89% accuracy across 38 studies involving 3,723 examinations [7]Verified Meta-Analytic Survey of Criterion Accuracy of Validated Polygraph Techniques
Confirms 89% accuracy for event-specific diagnostic tests across 38 studies involving 3,723 examinations. Blood pressure responses are integral to achieving this level of diagnostic capability. Surveys of published polygraph literature have similarly reported overall accuracy levels of.89 [8]Verified Survey of Published Polygraph Literature on Accuracy
Confirms overall polygraph accuracy level of.89 across published literature, while other reviews report accuracy exceeding.90 [9]Verified Review of Polygraph Accuracy Research
Confirms polygraph accuracy exceeding.90, consistent with other major reviews[10]Verified Accuracy of Polygraph Techniques
Confirms polygraph accuracy exceeding.90 using the CQT format.

Why Cardiac Health Directly Affects All Three Measurements

Every measurement captured by the cardio channel depends on normal cardiac function. When the heart's electrical conduction system, muscular contraction, or vascular regulation is compromised, the signals captured by the polygraph may not accurately reflect the examinee's psychological state. Instead, they may reflect the underlying pathology, medication effects, or device interference — creating noise that obscures the autonomic responses the examiner is trying to detect.

This is the fundamental problem with cardiac conditions and polygraph testing: the instrument cannot distinguish between a blood pressure increase caused by deception-related stress and one caused by a paroxysmal arrhythmia, a medication-induced bradycardia, or a pacemaker-initiated rhythm change. A published review in Military Medicine confirms that individuals with autonomic nervous system dysfunction could have inconclusive or false-negative polygraph results due to lack of variation between control and target questions [1]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers produce blunted physiologic responses leading to increased likelihood of inconclusive or false-negative polygraph results, and that many commonly prescribed medications affect ANS function relevant to polygraph testing. Similar concerns apply to conditions affecting other physiological channels, as discussed in our guides to Parkinson's disease and polygraph testing and dementia and polygraph testing.

The Dual Concern: Safety and Validity

Heart conditions present two distinct but equally important concerns for polygraph testing. The first is examinee safety — the risk that the psychological and physiological stress of a polygraph examination could trigger a dangerous cardiac event. The second is test validity — the concern that abnormal cardiac function will produce unreliable data that cannot be properly scored.

While a polygraph examination is not an extreme physical stressor comparable to exercise testing, it does involve sustained psychological stress over a period of 1.5 to 3 hours. During this time, the examinee experiences anticipatory anxiety, focused attention during question sequences, and repeated activation of the sympathetic nervous system. For someone with a healthy heart, this level of stress is well within safe limits. For someone with compromised cardiac function, however, even moderate sympathetic activation can have serious consequences. Similar to how sleep deprivation affects polygraph results, cardiac conditions can introduce confounding physiological noise that makes accurate interpretation difficult.

The Physiology of Stress During Polygraph Testing

When an examinee sits for a polygraph, the following physiological cascade occurs regardless of whether they are truthful or deceptive:

Catecholamine release — epinephrine and norepinephrine are released from the adrenal medulla, increasing heart rate and contractility.

Increased cardiac output — the heart pumps more blood per minute to prepare for potential action (the fight-or-flight response).

Peripheral vasoconstriction — blood vessels in the extremities narrow, redirecting blood to vital organs and raising blood pressure.

Myocardial oxygen demand increases — the working heart requires more oxygen, which is normally delivered by increasing coronary blood flow.

In a healthy cardiovascular system, these responses are adaptive and harmless. In a diseased heart, they can overwhelm compensatory mechanisms. For instance, a patient with coronary artery disease may not be able to increase coronary blood flow to meet the increased demand, leading to ischemia and potentially angina or myocardial infarction. A patient with heart failure may not be able to increase cardiac output effectively, leading to acute decompensation. A patient with an arrhythmia substrate may experience triggered activity or reentry circuits that produce dangerous rhythm disturbances.

Prevalence of Heart Conditions in the Testing Population

According to the American Heart Association's Heart Disease and Stroke Statistics, approximately 48% of all American adults have some form of cardiovascular disease when hypertension is included [11]Verified 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Confirms approximately 48% of American adults have some form of cardiovascular disease including hypertension. Among adults over 65, the prevalence is significantly higher, with adults age 65 and older showing a prevalence nearly 10 times that of adults ages 18-44 [12]Verified Cardiovascular Disease Prevalence in the United States
Confirms adults 65+ have prevalence nearly 10 times that of adults 18-44, and AHA projects CVD costs to reach $1,344 billion by 2050. The AHA projects cardiovascular disease costs will triple by 2050, reaching $1,344 billion [12]Verified Cardiovascular Disease Prevalence in the United States
Confirms adults 65+ have prevalence nearly 10 times that of adults 18-44, and AHA projects CVD costs to reach $1,344 billion by 2050.

This means that polygraph examiners will routinely encounter examinees with cardiac conditions, particularly in contexts where the testing population skews older — such as post-conviction sex offender testing (PCSOT) programs, workplace investigations involving senior employees, and private testing for domestic matters. Research by Grubin and Madsen (2006) found that polygraph testing in PCSOT produces actionable information for risk management [13]Verified Accuracy and Utility of Post-Conviction Polygraph Testing of Sex Offenders
Confirms polygraph testing in PCSOT produces actionable information for risk management, and Kokish et al. (2005) found the majority of sex offenders reported polygraph motivated them to be more honest in treatment [14]Verified Post-Conviction Sex Offender Polygraph Examination: Client-Reported Perceptions of Utility and Accuracy
Confirms majority of sex offenders reported polygraph motivated them to be more honest in treatment and supervision. Understanding which cardiac conditions are safe, which require precautions, and which are absolute contraindications is a fundamental competency for safe practice.

Understanding Arrhythmias in the Polygraph Context

Cardiac arrhythmias — disorders of heart rhythm — are among the most problematic conditions for polygraph testing because they directly compromise the cardiovascular channel data. Arrhythmias can be classified by location (atrial vs. ventricular), rate (tachycardia vs. bradycardia), and regularity (regular vs. irregular), and each classification carries different implications for both safety and test validity.

Atrial Fibrillation (AFib)

Atrial fibrillation is the most common sustained arrhythmia. A 2024 study published in JACC, using data from nearly 30 million patients in California, estimated that at least 10.55 million American adults (4.48%) have atrial fibrillation — three times higher than projections based on 1996-1997 data [15]Verified Minimum National Prevalence of Diagnosed Atrial Fibrillation Inferred From California Acute Care Facilities
Confirms at least 10.55 million American adults (4.48%) have atrial fibrillation, three times higher than prior estimates. A separate 2024 analysis using Epic's Cosmos platform found an overall AFib prevalence of 3.89% among US adults, with rates reaching 24.58% in those aged 90 and older [16]Verified Prevalence, Management, and Comorbidities of Adults With Atrial Fibrillation in the United States, 2019 to 2023
Confirms overall atrial fibrillation prevalence of 3.89% among US adults, reaching 24.58% in those aged 90+. In AFib, the atria quiver chaotically rather than contracting in a coordinated manner, resulting in an irregularly irregular ventricular response.

For polygraph testing, AFib presents these specific challenges:

Erratic pulse amplitude — beat-to-beat variation in stroke volume produces highly variable pulse waves on the cardio channel, making it extremely difficult to identify the subtle amplitude changes associated with deception.

Unreliable heart rate data — the ventricular rate in AFib varies widely from beat to beat, making it impossible to detect the small heart rate changes (typically 2-8 BPM) that examiners look for in response to relevant questions.

Blood pressure instability — the loss of atrial contribution to ventricular filling (known as the "atrial kick") reduces cardiac output. According to StatPearls (NIH), the atrial kick normally accounts for 20% to 30% of left ventricular filling in healthy individuals, and loss of atrial contraction has been shown to decrease cardiac output by 20% to 30% [17]Verified Atrial Kick — StatPearls
Confirms atrial kick accounts for 20-30% of left ventricular filling and loss of atrial contraction decreases cardiac output by 20-30%. This irregular rhythm causes beat-to-beat blood pressure variation that can obscure question-related pressure changes.

Safety assessment: For patients with rate-controlled, chronic AFib who are otherwise stable, the polygraph examination itself is unlikely to be dangerous. However, uncontrolled AFib with rapid ventricular response (heart rates above 100-110 BPM) is a contraindication to testing due to the risk of hemodynamic compromise during sustained stress. Patients with AFib who are anticoagulated should also be considered carefully, as the blood pressure cuff inflation could theoretically cause bruising or hematoma in susceptible individuals.

Accuracy assessment: AFib significantly degrades cardiovascular channel data quality. While an experienced examiner may still obtain useful data from the EDA and pneumograph channels, the loss of reliable cardio data reduces overall diagnostic capability. Many examiners consider uncontrolled AFib a relative contraindication to testing based on accuracy concerns alone.

Supraventricular Tachycardia (SVT)

SVT encompasses several arrhythmias originating above the ventricles, including AVNRT (AV nodal reentrant tachycardia) and AVRT (AV reentrant tachycardia, associated with Wolff-Parkinson-White syndrome). SVT episodes are typically paroxysmal — they come on suddenly and may last minutes to hours.

The primary concern with SVT is that psychological stress can trigger episodes. The catecholamine surge associated with polygraph testing could initiate an SVT episode during the examination, producing a sudden jump to heart rates of 150-250 BPM on the cardio channel. This would not only invalidate the chart in progress but could also cause the examinee significant distress, including palpitations, chest pain, shortness of breath, and lightheadedness.

Patients with well-controlled SVT (either through ablation or medication) who have not had a recent episode may be candidates for testing with medical clearance. Those with frequent, unpredictable episodes should generally be deferred.

Premature Ventricular Contractions (PVCs)

PVCs are early heartbeats originating from the ventricles. They are extremely common — with an estimated prevalence of 40% to 75% of subjects on 24- to 48-hour Holter monitoring [18]Verified Current Concepts of Premature Ventricular Contractions
Confirms PVC prevalence of 40-75% on 24-48 hour Holter monitoring in the general population. One population-based study of healthy adults aged 25 to 41 years found at least one PVC in 69% of participants on 24-hour Holter monitoring [19]Verified Evaluation and Management of Premature Ventricular Complexes
Confirms PVCs found in the majority on long-term ambulatory monitoring, with 69% prevalence in one community-based Holter study of healthy adults. The prevalence increases significantly with age and extended monitoring duration [19]Verified Evaluation and Management of Premature Ventricular Complexes
Confirms PVCs found in the majority on long-term ambulatory monitoring, with 69% prevalence in one community-based Holter study of healthy adults.

Occasional PVCs (fewer than 6 per minute) will appear as isolated artifact beats on the polygraph tracing but are unlikely to significantly impact chart quality if the examiner recognizes them and accounts for them in scoring. However, frequent PVCs (more than 6 per minute) or complex patterns (couplets, triplets, bigeminy, trigeminy) can significantly degrade cardio channel data quality and may indicate underlying structural heart disease that warrants further evaluation. A PVC burden greater than 10% is generally considered higher risk for the development of PVC-induced cardiomyopathy [20]Verified Management of Premature Ventricular Complexes in the Outpatient Setting
Confirms PVC burden >10% is generally considered higher risk for development of PVC-induced cardiomyopathy. Frequent PVCs that increase with stress are particularly problematic for polygraph accuracy.

Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF)

Any history of sustained ventricular tachycardia or ventricular fibrillation represents an absolute contraindication to polygraph testing unless the underlying cause has been definitively treated (e.g., successful catheter ablation with no recurrence). VT can degenerate into VF, which is a cardiac arrest rhythm. The stress of polygraph testing could potentially trigger VT in a susceptible individual. Patients with a history of VT/VF who have an implantable cardioverter-defibrillator (ICD) present additional considerations discussed in the pacemaker/ICD section below.

The Most Common Cardiac Condition in Polygraph Examinees

Hypertension (high blood pressure) is by far the most frequent cardiac condition that polygraph examiners encounter, affecting nearly half of American adults [11]Verified 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Confirms approximately 48% of American adults have some form of cardiovascular disease including hypertension. Because the polygraph's cardiovascular channel specifically measures blood pressure changes, hypertension has direct implications for both safety and data quality. Understanding the nuances of this condition is essential for every working examiner, just as understanding caffeine's effects on results helps ensure accurate testing.

Controlled vs. Uncontrolled Hypertension

The critical distinction is between controlled hypertension (blood pressure maintained at or near target levels through medication and/or lifestyle modifications) and uncontrolled hypertension (blood pressure consistently above target despite treatment, or untreated high blood pressure).

Controlled hypertension (BP < 140/90 mmHg on treatment): Generally safe for polygraph testing. The primary accuracy concern is that antihypertensive medications — particularly beta-blockers — may dampen cardiovascular reactivity. Research published in Military Medicine confirms that beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure, meaning a patient taking beta-blockers will have a blunted physiologic response to stress and an increased likelihood of an inconclusive or false-negative result [1]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers produce blunted physiologic responses leading to increased likelihood of inconclusive or false-negative polygraph results, and that many commonly prescribed medications affect ANS function relevant to polygraph testing. However, an experienced examiner can still obtain useful data and may weight other channels more heavily in their analysis. Research demonstrates that between-chart discussion of comparison questions can significantly improve CQT accuracy [21]Verified The Discussion of Comparison Questions Between List Repetitions Is Associated with Increased Test Accuracy
Confirms between-chart discussion of comparison questions significantly improved CQT accuracy, and structural improvements to testing protocols can further reduce error rates [22]Verified Confidence, Accuracy, and Utility of Polygraph Decisions
Confirms structural improvements to testing protocols can reduce error rates.

Uncontrolled hypertension (BP > 160/100 mmHg): Presents both safety and accuracy concerns. The added stress of the polygraph examination on an already elevated blood pressure increases the risk of hypertensive crisis, which can lead to stroke, heart attack, aortic dissection, or acute kidney injury. From an accuracy standpoint, a very high baseline blood pressure may leave less physiological room for the blood pressure increases associated with deception, as the cardiovascular system is already maximally or near-maximally activated.

Hypertensive Crisis During Testing

A hypertensive emergency (blood pressure above 180/120 mmHg with evidence of end-organ damage) is a life-threatening condition requiring immediate medical attention. Signs an examiner should watch for include:

Severe headache that develops or worsens during the examination. Visual disturbances — blurred vision, seeing spots, or partial vision loss. Chest pain or tightness. Shortness of breath not related to respiratory countermeasure detection. Confusion or altered mental status. Nosebleed that occurs spontaneously during testing. Nausea or vomiting.

If any of these signs appear during a polygraph examination, the examiner should immediately stop the test, deflate the blood pressure cuff, and call emergency medical services. This protocol should be part of every examiner's standard operating procedures.

White Coat Hypertension and the Pre-Test Phase

White coat hypertension — elevated blood pressure in clinical settings that normalizes in everyday life — is highly relevant to polygraph testing because many examinees experience significant anxiety about the examination. An examinee who normally has well-controlled blood pressure may present with elevated readings during the pre-test interview.

Examiners should take blood pressure readings at the beginning of the pre-test and again before chart collection begins. If readings remain severely elevated, postponement should be considered. The goal of the pre-test interview and preparation phase is partly to acclimate the examinee and reduce anxiety to manageable levels. An examinee whose blood pressure remains dangerously elevated despite a thorough and reassuring pre-test discussion may not be suitable for testing that day. For more on the baseline testing process, see our dedicated guide.

Congestive Heart Failure Classifications

Heart failure (HF) occurs when the heart cannot pump blood efficiently enough to meet the body's needs. The New York Heart Association (NYHA) classification system provides a useful framework for assessing polygraph suitability:

NYHA Class I — No Limitation: Ordinary physical activity does not cause symptoms. Patients in this class may be candidates for polygraph testing with physician clearance, as their compensatory mechanisms are still effective. The cardio channel data should be reasonably reliable if the heart rhythm is normal.

NYHA Class II — Slight Limitation: Comfortable at rest, but ordinary activity causes fatigue, palpitations, or dyspnea. Testing may be possible with physician clearance and careful monitoring, but the examination duration should be minimized. Reduced cardiac output may produce lower-amplitude pulse waves and less dynamic blood pressure responses.

NYHA Class III — Marked Limitation: Comfortable at rest, but less-than-ordinary activity causes symptoms. Testing is generally not recommended. The risk of acute decompensation during the sustained stress of a polygraph examination is significant, and the cardiovascular data quality will likely be poor due to severely compromised pump function.

NYHA Class IV — Severe Limitation: Symptoms at rest, with discomfort with any physical activity. This is an absolute contraindication to polygraph testing. The examination poses an unacceptable safety risk, and the physiological data would be entirely unreliable.

Cardiomyopathy Considerations

Cardiomyopathies — diseases of the heart muscle itself — include dilated cardiomyopathy, hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy (ARVC). Each has different implications:

Dilated cardiomyopathy — typically manifests as heart failure with reduced ejection fraction. Follow the NYHA classification guidance above.

Hypertrophic cardiomyopathy (HCM) — of particular concern because it is traditionally viewed as the most common condition responsible for sudden cardiac death (SCD) in young athletes, accounting for 35% to 50% of cases in the USA [23]Verified Hypertrophic Cardiomyopathy in Athletes
Confirms HCM is traditionally the most common condition responsible for sudden cardiac death in young athletes, identified in nearly 40% of cases in a series of 1,866 deaths. The American Heart Association identifies HCM as the leading cause of SCD in young athletes [24]Verified HCM in Young Adults and Student Athletes
Confirms HCM is the leading cause of sudden cardiac death in young athletes and an estimated 1 in 500 people have HCM. An estimated 1 in 500 people have HCM, though many cases remain undiagnosed [24]Verified HCM in Young Adults and Student Athletes
Confirms HCM is the leading cause of sudden cardiac death in young athletes and an estimated 1 in 500 people have HCM. The thickened septum can cause dynamic left ventricular outflow tract obstruction that worsens with sympathetic activation. Stress-induced catecholamine release during polygraph testing could increase obstruction and potentially trigger dangerous arrhythmias. HCM should generally be considered a contraindication unless the patient's cardiologist specifically clears them for stress-inducing procedures.

ARVC — associated with ventricular arrhythmias triggered by sympathetic activation. Represents a contraindication to polygraph testing due to the risk of exercise- and stress-triggered VT/VF.

How Pacemakers Affect Polygraph Data

Nearly 3 million Americans are currently living with a pacemaker [2]Verified What Is a Pacemaker? 5 Things to Know About the Device
Confirms nearly 3 million Americans are living with a pacemaker and more than 70% of recipients are 65 or older, with approximately 200,000 new implants performed in the United States each year [25]Verified Leadless Pacemakers: A Contemporary Review
Confirms approximately 200,000 pacemakers are implanted in the United States annually. More than 70% of pacemaker recipients are 65 or older [2]Verified What Is a Pacemaker? 5 Things to Know About the Device
Confirms nearly 3 million Americans are living with a pacemaker and more than 70% of recipients are 65 or older. Examiners will encounter pacemaker patients with increasing frequency as the population ages, particularly in PCSOT programs and private testing involving older examinees.

A pacemaker delivers electrical impulses to the heart when its natural rhythm is too slow or unreliable. The device may pace the atria, ventricles, or both (dual-chamber pacing). The Heart Rhythm Society reports that more than 300,000 individuals receive new cardiac implantable electronic device implants every year in the U.S. [26]Verified Heart Rhythm 2024 Spotlights New Developments in CIEDs
Confirms more than 300,000 individuals receive new cardiac implantable electronic device implants every year in the U.S..

The fundamental problem for polygraph testing is that a pacemaker prevents the heart rate from dropping below a programmed lower rate limit (typically 60 BPM). This means the polygraph may not capture normal heart rate variability patterns. If the pacemaker is set to rate-responsive mode, it will increase heart rate based on sensor input (usually activity-based or minute ventilation-based), but this may not correlate with the psychological stress that the examiner is attempting to measure.

From an accuracy standpoint, a pacemaker effectively introduces an artificial floor on heart rate data and may mask the subtle heart rate changes (typically 2-8 BPM) that indicate responses to relevant versus comparison questions. Examiners testing pacemaker patients should rely more heavily on the EDA and pneumograph channels, and the examination report should note the device and its potential impact on cardiovascular data quality.

Implantable Cardioverter-Defibrillators (ICDs)

An ICD is a more complex device than a pacemaker — it not only provides pacing but can deliver high-energy shocks to terminate life-threatening ventricular arrhythmias. The presence of an ICD indicates that the patient has been assessed as being at significant risk for sudden cardiac death.

The primary safety concern with ICD patients is that the stress of polygraph testing could trigger a ventricular arrhythmia that causes the device to deliver a shock. An ICD shock is extremely painful and distressing, and multiple shocks can be medically dangerous. The electromagnetic fields from the polygraph equipment itself are unlikely to interfere with modern ICDs, but the psychological stress of the examination is the real concern.

For patients with ICDs placed for primary prevention (no prior cardiac arrest), testing may be possible with explicit cardiologist clearance. For patients with ICDs placed for secondary prevention (prior cardiac arrest or sustained VT), testing should generally be avoided due to the demonstrated susceptibility to stress-triggered arrhythmias.

Post-Myocardial Infarction Recovery Period

A recent myocardial infarction (heart attack) represents both a safety contraindication and an accuracy concern. In the acute phase (first 6-8 weeks), the damaged myocardium is healing and is highly susceptible to arrhythmias, recurrent ischemia, and mechanical complications. Polygraph testing should never be conducted during this period.

Between 3-6 months post-MI, the risk gradually decreases as the myocardium heals and scar tissue stabilizes. However, the patient's cardiovascular responses may still be abnormal due to ongoing remodeling, medication effects, and reduced cardiac reserve.

After 6-12 months with documented cardiac rehabilitation completion, successful stress testing, and cardiologist clearance, many post-MI patients can safely undergo polygraph testing. The examiner should be aware that residual left ventricular dysfunction, beta-blocker therapy, and antiplatelet medications may affect cardiovascular channel data quality.

Post-Cardiac Surgery Considerations

Patients who have undergone coronary artery bypass grafting (CABG), valve repair or replacement, or other cardiac surgeries require a minimum recovery period before polygraph testing is appropriate. Generally, a minimum of 6 months post-surgery with documented recovery and physician clearance should be observed.

Specific considerations include: Sternotomy healing — the physical discomfort of sitting in a polygraph chair for 1.5-3 hours may cause chest wall pain that affects breathing patterns and indirectly impacts pneumograph data. Post-operative arrhythmias — atrial fibrillation occurs in up to 30-40% of patients following cardiac surgery and may persist for weeks to months. Medication regimens — post-surgical patients are typically on multiple cardiovascular medications that may affect physiological reactivity.

Beta-Blockers

Beta-blockers (e.g., metoprolol, atenolol, propranolol, carvedilol) are among the most commonly prescribed cardiac medications and have the most significant impact on polygraph data. They reduce beta-adrenergic receptor activation in cardiac muscle and blood vessels, lowering heart rate, heart rate variability, cardiac contractility, and blood pressure [1]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms beta-blockers produce blunted physiologic responses leading to increased likelihood of inconclusive or false-negative polygraph results, and that many commonly prescribed medications affect ANS function relevant to polygraph testing.

The Office of Technology Assessment reported that propranolol resulted in a 32.2% inconclusive rate in one study, although the overall error rate remained low [27]Verified Scientific Validity of Polygraph Testing (OTA Report — Chapter 6)
Confirms propranolol resulted in a 32.2% inconclusive rate in analog study, with low overall error rate, and examiners could not detect drug use. An additional finding was that examiners could not tell which subjects had used the drug [27]Verified Scientific Validity of Polygraph Testing (OTA Report — Chapter 6)
Confirms propranolol resulted in a 32.2% inconclusive rate in analog study, with low overall error rate, and examiners could not detect drug use. Multiple published studies referenced by the National Academies note that the use of such drugs in a CQT examination would be more likely to yield inconclusive findings rather than outright errors, because the drugs suppress responses to both control and relevant questions equally [27]Verified Scientific Validity of Polygraph Testing (OTA Report — Chapter 6)
Confirms propranolol resulted in a 32.2% inconclusive rate in analog study, with low overall error rate, and examiners could not detect drug use.

For the polygraph examiner, the key consideration is that a patient on beta-blockers may show dampened cardiovascular responses to both relevant and comparison questions. This can lead to flat or low-amplitude tracings on the cardio channel. An experienced examiner will weight the EDA and pneumograph channels more heavily and note the beta-blocker use in their examination report. For additional context on substances that affect results, see our guide on caffeine and polygraph testing.

Other Cardiovascular Medications

Calcium channel blockers (e.g., amlodipine, diltiazem, verapamil) — rate-limiting calcium channel blockers (diltiazem, verapamil) slow heart rate and reduce blood pressure, creating effects similar to beta-blockers on the cardio channel. Dihydropyridine calcium channel blockers (amlodipine, nifedipine) primarily affect blood pressure without significant heart rate reduction and have less impact on polygraph data.

ACE inhibitors and ARBs (e.g., lisinopril, losartan) — these medications lower blood pressure by affecting the renin-angiotensin system. Their effect on polygraph data is relatively modest compared to beta-blockers, as they do not significantly affect heart rate or autonomic reactivity.

Antiarrhythmic medications (e.g., amiodarone, flecainide, sotalol) — these drugs modify cardiac electrical activity and may produce unusual heart rate patterns or reduced heart rate variability. Sotalol, which has both antiarrhythmic and beta-blocking properties, is of particular concern.

Anticoagulants — warfarin and direct oral anticoagulants (DOACs) like apixaban, rivaroxaban, dabigatran, and edoxaban [28]Verified Direct Oral Anticoagulants: A Quick Guide
Confirms the four DOACs are dabigatran, rivaroxaban, apixaban, and edoxaban (correct spelling of rivaroxaban) do not directly affect the physiological responses measured by the polygraph. However, they raise a safety consideration: the blood pressure cuff inflation during chart collection could potentially cause bruising or hematoma in patients who are fully anticoagulated. Examiners should use minimal cuff pressure and monitor for signs of discomfort.

Professional Standards for Medical Screening

The American Polygraph Association (APA) Standards of Practice require that basic inquiries into the medical and psychological condition of the examinee should be made where allowed by law [3]Verified APA Standards of Practice
Confirms APA requires basic inquiries into the medical and psychological condition of the examinee and that observable health conditions should be considered when conducting examinations. Mental, physical, or medical conditions of the examinee that are observable by or reasonably known to the examiner should be considered when conducting and evaluating an examination [3]Verified APA Standards of Practice
Confirms APA requires basic inquiries into the medical and psychological condition of the examinee and that observable health conditions should be considered when conducting examinations.

The APA's Model Policy for the Evaluation of Examinee Suitability for Polygraph Testing further specifies that examiners should conduct all examinations in a manner sensitive to any medical, mental health, or developmental issues that may affect the examinee's functioning or the quality of the examination data [29]Verified APA Model Policy for the Evaluation of Examinee Suitability for Polygraph Testing
Confirms examiners should conduct examinations sensitive to medical, mental health, and developmental issues, and testing must not jeopardize examinee health or safety. The model policy requires examiners to ensure that the testing process will not jeopardize the health or safety of the examinee [29]Verified APA Model Policy for the Evaluation of Examinee Suitability for Polygraph Testing
Confirms examiners should conduct examinations sensitive to medical, mental health, and developmental issues, and testing must not jeopardize examinee health or safety. Professional guidelines from the APA, ASTM E2031, and ENFSI all emphasize that examiners have a duty to recognize health issues that may compromise validity, and examinations must not be conducted if physical or mental health conditions could distort physiological responses [30]Verified Medical and Psychological Conditions Affecting Polygraph Examinations
Confirms professional guidelines (APA, ASTM E2031, ENFSI) require examiners to recognize health issues and prohibit testing when health conditions could distort physiological responses.

Polygraph examinations will not be conducted on any person who the examiner reasonably believes to be physically or emotionally unsuitable for testing [31]Verified Policy 906 — Polygraph Examinations
Confirms polygraph examinations will not be conducted on any person the examiner reasonably believes to be physically or emotionally unsuitable for testing. If the examiner is unsure of the examinee's physical suitability, they should seek physician clearance before proceeding [31]Verified Policy 906 — Polygraph Examinations
Confirms polygraph examinations will not be conducted on any person the examiner reasonably believes to be physically or emotionally unsuitable for testing.

Pre-Test Medical Screening Procedures

A comprehensive pre-test medical screening for cardiac conditions should include:

A standardized health questionnaire covering history of heart disease, arrhythmias, heart failure, prior cardiac events, surgeries, and implanted devices [30]Verified Medical and Psychological Conditions Affecting Polygraph Examinations
Confirms professional guidelines (APA, ASTM E2031, ENFSI) require examiners to recognize health issues and prohibit testing when health conditions could distort physiological responses. A complete medication inventory including all prescription and over-the-counter medications, with particular attention to beta-blockers, calcium channel blockers, antiarrhythmics, and anticoagulants. Blood pressure measurement at the beginning of the pre-test phase, with repeat measurement before chart collection if initial readings are elevated. Observation of physical comfort, including signs of shortness of breath, chest discomfort, or other cardiac symptoms.

Examiners encountering examinees with known cardiac conditions should obtain written physician clearance before proceeding with testing. The clearance letter should specifically address whether the patient can safely undergo 1.5-3 hours of sustained psychological stress and whether any of their medications are likely to significantly affect autonomic reactivity. For more details on the pre-test process, see our guide to the polygraph pre-test questionnaire.

Absolute Contraindications

Polygraph testing should be declined entirely when any of the following conditions are present:

Unstable angina or acute coronary syndrome. Recent myocardial infarction (within 6 months). NYHA Class IV heart failure. Uncontrolled ventricular arrhythmias (VT or VF) without a definitive treatment. Severe uncontrolled hypertension (BP > 180/120 mmHg). Active myocarditis or pericarditis. Recent cardiac surgery (within 6 months). Symptomatic aortic stenosis. Known hypertrophic cardiomyopathy with obstruction (unless specifically cleared by cardiologist). Arrhythmogenic right ventricular cardiomyopathy.

In these cases, the examiner should document the reason for declining the examination and advise the requesting party of the medical contraindication. If the examination is legally required, as in some PCSOT programs, the examiner should coordinate with the supervising officer and the examinee's physician to determine an appropriate timeline for reassessment.

Relative Contraindications Requiring Physician Clearance

The following conditions may allow testing with appropriate precautions and physician clearance:

Controlled atrial fibrillation with stable rate. Well-managed chronic heart failure (NYHA Class I-II). History of SVT with successful ablation or medical management. Stable hypertension on medication (BP < 140/90 mmHg). Pacemaker (at least 3 months post-implantation with stable settings). Post-MI greater than 12 months with completed cardiac rehabilitation. Post-cardiac surgery greater than 6 months with documented recovery.

For each of these conditions, the examiner should document the physician clearance, note the condition and medications in the examination report, and qualify the test results to reflect any potential impact on cardiovascular channel data. Understanding the principles behind polygraph examination disqualification helps both examiners and examinees navigate these situations appropriately.

Options for Examinees Unable to Take a Polygraph

When a polygraph examination is medically contraindicated, several alternative approaches may be considered depending on the context:

For PCSOT programs: treatment providers can use enhanced clinical interviews, self-report questionnaires, and behavioral monitoring to gather information that polygraph examinations would normally elicit. The therapeutic value of accountability mechanisms in sex offender rehabilitation remains significant even when polygraph is not possible [13]Verified Accuracy and Utility of Post-Conviction Polygraph Testing of Sex Offenders
Confirms polygraph testing in PCSOT produces actionable information for risk management[14]Verified Post-Conviction Sex Offender Polygraph Examination: Client-Reported Perceptions of Utility and Accuracy
Confirms majority of sex offenders reported polygraph motivated them to be more honest in treatment and supervision.

For legal proceedings: attorneys may consider other forms of evidence or investigation. Some emerging technologies such as EyeDetect or neuroscience-based tests may be suitable alternatives for examinees with cardiac contraindications, as these methods do not rely on cardiovascular measurements.

For employment screening: the Employee Polygraph Protection Act already restricts most private-sector employers from using polygraphs, and for government employers, a medical waiver process may be available when an applicant has a documented cardiac condition that precludes testing.

In all cases, the decision to forgo polygraph testing should be documented, including the specific medical reason, the physician's recommendation, and any alternative measures being pursued.